Challenges for HIV Pre-Exposure Prophylaxis among Men Who Have Sex with Men in the United States
暂无分享,去创建一个
[1] Michael Rayment,et al. Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.
[2] Sally Blower,et al. Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance , 2011, Scientific reports.
[3] G. Mansergh,et al. Condom-Use Decision Making in the Context of Hypothetical Pre-Exposure Prophylaxis Efficacy Among Substance-Using Men Who Have Sex With Men: Project MIX , 2011, Journal of acquired immune deficiency syndromes.
[4] K. Amico,et al. Standard of Care for Antiretroviral Therapy Adherence and Retention in Care from the Perspective of Care Providers Attending the 5th International Conference on HIV Treatment Adherence , 2011, Journal of the International Association of Physicians in AIDS Care.
[5] Arthur W. Wetzel,et al. Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout of Antiretroviral Pre-Exposure Prophylaxis (PrEP) , 2011, PloS one.
[6] S. Buchbinder,et al. Pre-Exposure Prophylaxis and the Promise of Combination Prevention Approaches , 2011, AIDS and Behavior.
[7] K. Mayer,et al. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings. , 2011, AIDS patient care and STDs.
[8] A. Lansky,et al. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. , 2011, MMWR. Morbidity and mortality weekly report.
[9] David V Glidden,et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.
[10] G. Mansergh,et al. Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men. , 2010, Journal of acquired immune deficiency syndromes.
[11] M. Mimiaga,et al. Implementation Science of Pre-exposure Prophylaxis: Preparing for Public Use , 2010, Current HIV/AIDS reports.
[12] R. Walensky,et al. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] Kenneth H Mayer,et al. Preexposure Antiretroviral Prophylaxis Attitudes in High-Risk Boston Area Men Who Report Having Sex With Men: Limited Knowledge and Experience but Potential for Increased Utilization After Education , 2009, Journal of acquired immune deficiency syndromes.